To verify the interaction between TRIM16 and OPTN in GBM cells, we performed multiple analyses, including Co‐IP, Bimolecular fluorescence complementation (BIFC), Duo‐link proximity ligation assay (PLA), and immunofluorescence co‐localization. The gene discussed is OPTN; the disease is glioblastoma.